📰 Medtrace Pharma News
Medtrace Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Medtrace Pharma. Real-time updates on events, politics, business and more.
September 21, 2023
MedTrace Pharma has raised €18.2 million to complete the Phase 3 trial of its tech to make PET with oxygen-15 labeled water widely available.
March 23, 2023
N.B. This is an unofficial translation of the Swedish original wording. In case of differences between the English translation and the Swedish original, the Swedish text shall... | March 23, 2023
March 23, 2023
XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL) (FRA:3XV) XVIVO Perfusion AB (publ) (the "Company"), reg. no. 556561-0424, with its registered office in Gothenburg, gives notice of the the Annual General Meeting to be held on Tuesday 25 April 2023...
March 23, 2023
Notice to attend the Annual General Meeting in XVIVO Perfusion AB (publ) ...
March 23, 2023
GOTHENBURG, SE / ACCESSWIRE / March 23, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL) (FRA:3XV) XVIVO Perfusion AB (publ) (the "Company"), reg. no. 556561-0424, with its registered office in Gothenburg
January 30, 2023
MedTrace Pharma seeks to make PET with oxygen-15 labeled water widely available in clinical settings for heart diagnostics.
September 21, 2022
After selling its Plymouth campus, Prudential makes the move to the urban core of Minneapolis, giving downtown a boost.
May 23, 2022
MedTrace Pharma announced the first person scanned in a Phase 3 clinical trial, further testing its tech to bring 15 O-water to imaging.